D.A. Davidson & Co’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-1,160
Closed -$335K 1303
2021
Q3
$335K Sell
1,160
-1
-0.1% -$257 ﹤0.01% 970
2021
Q2
$232K Sell
1,161
-20
-2% -$3.88K ﹤0.01% 1082
2021
Q1
$230K Buy
+1,181
New +$242K ﹤0.01% 1050

Other funds holding RGEN

D.A. Davidson & Co's RGEN Position: Q4 2021 in Review

D.A. Davidson & Co sold out of Repligen (RGEN) in Q4 2021, closing a stake of 1,160 shares — an estimated $335K sold.

D.A. Davidson & Co first reported a position in RGEN in Q1 2021 and held it in 3 quarters. The position peaked at $335K in Q3 2021. 507 funds tracked by Wall St. Rank hold RGEN as of Q4 2021.

  • D.A. Davidson & Co reported no remaining Repligen position as of Q4 2021 after selling out during the quarter.
  • D.A. Davidson & Co sold 1,160 Repligen shares in Q4 2021, an estimated $335K.
  • D.A. Davidson & Co first reported a position in Repligen in Q1 2021 and held it in 3 quarters.
  • D.A. Davidson & Co's Repligen position peaked at $335K in Q3 2021.
  • 507 funds tracked by Wall St. Rank held Repligen as of Q4 2021.

Based on D.A. Davidson & Co's 13F filing for Q4 2021, filed 31 Jan 2022.